Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie E Combs

Showing results (511-520 of 567) with videos related to

Pageof 57
Sort By:
Cancers|April 30, 2021
Prognostic Assessment in High-Grade Soft-Tissue Sarcoma Patients: A Comparison of Semantic Image Analysis and RadiomicsJan C Peeken, Jan Neumann, Rebecca Asadpour, et al.
Cancers|October 14, 2023
Multitask Learning with Convolutional Neural Networks and Vision Transformers Can Improve Outcome Prediction for Head and Neck Cancer PatientsSebastian Starke, Alex Zwanenburg, Karoline Leger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 14, 2018
Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: A multicenter DKTK/ROG analysisMaximilian Niyazi, Sebastian Adeberg, David Kaul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2020
Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical TrialGabriele Multhoff, Sophie Seier, Stefan Stangl, et al.
Cancers|October 22, 2020
Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCCStefan Leger, Alex Zwanenburg, Karoline Leger, et al.
Frontiers in Oncology|April 8, 2025
RAS70 peptide targets multiforme glioblastoma by binding to the plasma membrane heat shock protein HSP70Maxim Shevtsov, Natalia Yudintceva, Danila Bobkov, et al.
Scientific Reports|October 18, 2017
A comparative study of machine learning methods for time-to-event survival data for radiomics risk modellingStefan Leger, Alex Zwanenburg, Karoline Pilz, et al.
International Journal of Cancer|May 9, 2017
The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)Panagiotis Balermpas, Franz Rödel, Mechthild Krause, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 7, 2014
HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)Fabian Lohaus, Annett Linge, Inge Tinhofer, et al.
Scientific Reports|October 6, 2022
Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCCAsier Rabasco Meneghetti, Alex Zwanenburg, Annett Linge, et al.
Pageof 57

Showing results (511-520 of 567) with videos related to

Sort By:
Pageof 57
Cancers|April 30, 2021
Prognostic Assessment in High-Grade Soft-Tissue Sarcoma Patients: A Comparison of Semantic Image Analysis and RadiomicsJan C Peeken, Jan Neumann, Rebecca Asadpour, et al.
Cancers|October 14, 2023
Multitask Learning with Convolutional Neural Networks and Vision Transformers Can Improve Outcome Prediction for Head and Neck Cancer PatientsSebastian Starke, Alex Zwanenburg, Karoline Leger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 14, 2018
Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: A multicenter DKTK/ROG analysisMaximilian Niyazi, Sebastian Adeberg, David Kaul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2020
Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical TrialGabriele Multhoff, Sophie Seier, Stefan Stangl, et al.
Cancers|October 22, 2020
Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCCStefan Leger, Alex Zwanenburg, Karoline Leger, et al.
Frontiers in Oncology|April 8, 2025
RAS70 peptide targets multiforme glioblastoma by binding to the plasma membrane heat shock protein HSP70Maxim Shevtsov, Natalia Yudintceva, Danila Bobkov, et al.
Scientific Reports|October 18, 2017
A comparative study of machine learning methods for time-to-event survival data for radiomics risk modellingStefan Leger, Alex Zwanenburg, Karoline Pilz, et al.
International Journal of Cancer|May 9, 2017
The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)Panagiotis Balermpas, Franz Rödel, Mechthild Krause, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 7, 2014
HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)Fabian Lohaus, Annett Linge, Inge Tinhofer, et al.
Scientific Reports|October 6, 2022
Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCCAsier Rabasco Meneghetti, Alex Zwanenburg, Annett Linge, et al.
Pageof 57